Cite
MLA Citation
Christopher Koh et al.. “Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.” Lancet infectious diseases, vol. 15, no. 10, n.d., pp. 1167–1174. http://access.bl.uk/ark:/81055/vdc_100026575271.0x00000b